EVALUATION OF TUMOR ANTIGEN-SPECIFIC ANTIBODY RESPONSES IN PATIENTS WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER TREATED WITH CYCLOPHOSPHAMIDE AND PEMBROLIZUMAB

Category Primary study
JournalJournal for ImmunoTherapy of Cancer
Year 2022
This article has no abstract
Epistemonikos ID: 42e76bc30029c72355118929da381746d91d6579
First added on: Feb 15, 2025